Cargando…
Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report
INTRODUCTION: Transient myeloproliferative disorder is a hematologic abnormality characterized by an uncontrolled proliferation of myeloblasts in peripheral blood and bone marrow that primarily affects newborns and babies with Down syndrome. Tumor lysis syndrome is rarely associated with transient m...
Autores principales: | Tragiannidis, Athanasios, Pana, Zoe Dorothea, Papageorgiou, Theodotis, Hatzipantelis, Emmanuel, Hatzistilianou, Maria, Athanassiadou, Fani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180414/ https://www.ncbi.nlm.nih.gov/pubmed/21861929 http://dx.doi.org/10.1186/1752-1947-5-407 |
Ejemplares similares
-
Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
por: Alakel, Nael, et al.
Publicado: (2017) -
Primary posterior mediastinal germ cell tumor in a child
por: Gkampeta, Anastasia, et al.
Publicado: (2019) -
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
por: Cammalleri, Lisa, et al.
Publicado: (2007) -
Lumbar puncture complicated by spinal epidural hematoma in a child with leukemia
por: Hatzipantelis, Emmanuel, et al.
Publicado: (2015) -
Rare non-Wilms' tumors in children
por: Kourti, Maria, et al.
Publicado: (2012)